Search

everythinglearnresearchcommunity

for

Search:↓

The new compound may be a safer alternative to finasteride for prostate protection.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Dihydrotestosterone (DHT) increases oil production in skin cells by activating mTOR, and mTOR inhibitors can reduce this effect.

Anabolic steroids boost muscle growth, SARMs increase muscle mass and bone density without side effects, and myostatin inhibitors block a protein that stops muscle growth, but each has potential risks.

PM-9 and finasteride effectively inhibit the enzyme that converts testosterone to DHT.

DA-9401 helps protect rat testis from finasteride damage.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

Finasteride helps female-pattern hair loss.

The drug combination was safe and showed promise in treating advanced tumors.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Tadalafil and Finasteride may help treat aggressive melanoma.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

A new compound, BOI, can help hair grow by changing hair cycle phases and increasing certain cell contents.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

GI197111X is best dissolved in Capmul MCM for trials.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

P311 helps skin stem cells become myofibroblast-like cells, aiding wound healing.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Danoprevir, remdesivir, and saridegib may effectively inhibit SARS-CoV-2.

The document concludes that various topical treatments show promise for skin conditions like atopic dermatitis, psoriasis, and hair loss.